News | February 23, 2022
WHO establishes biomanufacturing training hub in South Korea
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
Launching in 2022, its availability will be expanded to the global market
Presbyopia, the age-related loss of near vision, could soon be treated successfully
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment
The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
Subscribe To Our Newsletter & Stay Updated
